Ecto

company

About

Ecto is a digital biology company developing technology to make protein production more efficient and sustainable

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$7M
Industries
Aquaculture,Biotechnology,Health Diagnostics,Information Technology
Founded date
Nov 18, 2013
Number Of Employee
11 - 50
Operating Status
Active

Ecto develops technology at the intersection of data and biology to enable a more efficient and sustainable aquaculture industry. They collaborate with farmers to streamline production and health management by leveraging advanced molecular tools and digital technologies. To date, Ecto's solutions have enabled farmers to create 51,510,714 additional healthy servings of protein.

Ecto has offices in Boston, Atlanta, and Stavanger Norway, and serves customers all over the world. The company was founded at Harvard Innovation Labs in 2013 by Dmitry Kozachenok and James Webb. The company has received competitive research grants from the US National Science Foundation, US Department of Agriculture, and Innovation Norway.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$12.71M
Ecto has raised a total of $12.71M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2021 Series A $7M 1 Detail
Jun 21, 2019 Grant $225K 1 National Science Foundation Detail
Oct 26, 2017 Series Unknown $5.48M 1 Aqua Spark Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Ecto is funded by 2 investors. National Science Foundation and Aqua Spark are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Aqua Spark Series A